DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+29.78%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$3.06B
AUM Growth
+$3.06B
(+14%)
Cap. Flow
+$87M
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
47.63%
Holding
153
New
43
Increased
25
Reduced
27
Closed
26
Top Buys
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$150M |
| 2 |
AbbVie
ABBV
|
$89.8M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$48.9M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$43.4M |
| 5 |
Larimar Therapeutics
LRMR
|
$41.6M |
Top Sells
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$216M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$129M |
| 3 |
RNA
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
|
$62.2M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$40.5M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$39.3M |
Sector Composition
| 1 | Healthcare | 61.01% |
| 2 | Financials | 2.54% |
| 3 | Technology | 0.47% |
| 4 | Industrials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHN
26
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $27.7M | 0.9% |
2,810,164
-110,136
| -4% | -$1.09M |
|
27
Charles River Laboratories
CRL
$7.99B
| $23M | 0.74% |
+289,450
| New | +$23M |
|
28
Orthofix Medical
OFIX
$583M
| $22.6M | 0.73% |
630,222
+96,410
| +18% | +$3.46M |
|
|
ALIM
29
DELISTED
Alimera Sciences, Inc.
ALIM
| $22.1M | 0.72% |
4,420,580
+374,754
| +9% | +$1.88M |
|
|
PTLA
30
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $21.8M | 0.71% |
574,546
-81,013
| -12% | -$3.08M |
|
31
McKesson
MCK
$85.9B
| $20.8M | 0.67% |
92,000
| – | – |
|
|
LOXO
32
DELISTED
Loxo Oncology, Inc
LOXO
| $19.8M | 0.64% |
1,591,546
| – | – |
|
33
Inogen
INGN
$213M
| $19.3M | 0.62% |
601,772
+247,442
| +70% | +$7.92M |
|
|
AERI
34
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $19M | 0.62% |
606,118
-1,252,799
| -67% | -$39.3M |
|
|
DYAX
35
DELISTED
DYAX CORPORATION
DYAX
| $19M | 0.61% |
1,131,414
+148,669
| +15% | +$2.49M |
|
36
Humana
HUM
$37.5B
| $18.9M | 0.61% |
+106,300
| New | +$18.9M |
|
37
Pacific Biosciences
PACB
$378M
| $17.8M | 0.58% |
3,048,310
-2,072,461
| -40% | -$12.1M |
|
38
Trupanion
TRUP
$1.9B
| $16.8M | 0.54% |
2,101,848
-576,328
| -22% | -$4.61M |
|
|
NUVA
39
DELISTED
NuVasive, Inc.
NUVA
| $15.6M | 0.5% |
+338,194
| New | +$15.6M |
|
40
Elevance Health
ELV
$72.4B
| $15.4M | 0.5% |
+99,742
| New | +$15.4M |
|
|
NSTG
41
DELISTED
NanoString Technologies, Inc.
NSTG
| $14.9M | 0.48% |
1,460,652
+537,274
| +58% | +$5.47M |
|
42
Protara Therapeutics
TARA
$125M
| $14.7M | 0.48% |
1,265,343
| – | – |
|
|
IMPR
43
DELISTED
IMPRIVATA, INC COM
IMPR
| $14.4M | 0.47% |
1,025,652
+27,400
| +3% | +$384K |
|
44
Tempest Therapeutics
TPST
$46.6M
| $14.1M | 0.46% |
407,108
-219,942
| -35% | -$7.63M |
|
|
AAC
45
DELISTED
AAC Holdings, Inc.
AAC
| $13.6M | 0.44% |
+446,328
| New | +$13.6M |
|
46
Axogen
AXGN
$718M
| $13.5M | 0.44% |
3,870,824
+2,363,000
| +157% | +$8.27M |
|
47
TherapeuticsMD
TXMD
$12.7M
| $13.5M | 0.44% |
+2,223,310
| New | +$13.5M |
|
|
JUNO
48
DELISTED
Juno Therapeutics, Inc.
JUNO
| $11.1M | 0.36% |
183,149
-175,000
| -49% | -$10.6M |
|
|
STDY
49
DELISTED
SteadyMed Ltd
STDY
| $10.8M | 0.35% |
+1,267,733
| New | +$10.8M |
|
|
TRIV
50
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $10.4M | 0.34% |
990,202
-158,373
| -14% | -$1.66M |
|